ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis

Wu, Zixuan; Jiang, Yanhui; Huang, Xuyan; Cai, Minjie; Yuan, Kai*; Huang, Peidong*; Wang, Zuhong广州中医药大学; 云南大学
Evidence-based Complementary and Alternative Medicine2022-4-15DOI: 10.1155/2022/7730433
3阅读
引用收藏
分享

摘要

Background. Previous research suggested that ETS1 (ETS proto-oncogene 1, transcription factor) could be useful for cancer immunotherapy. The processes underlying its therapeutic potential, on the other hand, have yet to be thoroughly investigated. The purpose of this study was to look into the relationship between ETS1 expression and immunity. Methods. TCGA and GEO provide raw data on 33 different cancers as well as GSE67501, GSE78220, and IMvigor210. In addition, we looked at ETS1's genetic changes, expression patterns, and survival studies. The linkages between ETS1 and TME, as well as its association with immunological processes/elements and the major histocompatibility complex, were explored to effectively understand the role of ETS1 in cancer immunotherapy. Three distinct immunotherapeutic cohorts were employed to examine the relationship between ETS1 and immunotherapeutic response. Results. ETS1 expression was shown to be high in tumor tissue. ETS1 overexpression is linked to a worse clinical outcome in individuals with overall survival. Immune cell infiltration, immunological modulators, and immunotherapeutic signs are all linked to ETS1. Overexpression of ETS1 is linked to immune-related pathways. However, no statistically significant link was found between ETS1 and immunotherapeutic response. Conclusions. ETS1 may be a reliable biomarker for tumor prognosis and a viable prospective therapeutic target for human cancer immunotherapy (e.g., KIRP, MESO, BLCA, KIRC, and THYM).

学科与关键词

关键词
TRANSCRIPTION FACTOR ETS1
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Evidence-based Complementary and Alternative Medicine
发表日期
2022-04-15
卷期
第 2022 卷
页码
7730433
DOI
10.1155/2022/7730433
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Health and Health Commission of Yunnan Province 2020 High-level TCM Reserve Talents Incubation Project (Yunwei TCM Development); Health and Health Commission of Yunnan Province 2020 High-level TCM Reserve Talents Incubation Project [1]; Second Round of Construction Project of The National Traditional Chinese Medicine School Heritage Studio of the State Administration of Traditional Chinese Medicine [[2019] 62]; Scientific and Technological Innovation Team of Acupuncture and Moxibustion Prevention and Treatment of Mental Disorders in Yunnan Colleges and Universities [2019YGC04]; Research and Development of Pediatric Cerebral Palsy Tuina Rehabilitation Equipment Based on Big Data Artificial Intelligence (Major Science and Technology Special Project of Yunnan Provincial Science and Technology Department-Biomedical Special Project) [202002AA100141]

作者

  • W

    Wu, Zixuan (第一作者)

    guangzhou univ chinese med

  • J

    Jiang, Yanhui

    guangzhou univ chinese med

查看全部 7 位作者收起作者
  • H

    Huang, Xuyan

    guangzhou univ chinese med

  • C

    Cai, Minjie

  • Y

    Yuan, Kai (通讯)

    yunnan univ

  • H

    Huang, Peidong (通讯)

    yunnan univ

  • W

    Wang, Zuhong

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417